Detail

Study ID: Vyriad Solid Tumor VYR-VSV2-101

Title:

Phase I Trial of Intratumoral Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and human interferon beta (VSV-IFN-ß-NIS), in Patients with Refractory Solid Tumors

Description:
Title: Vyriad Phase 1 trial of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon Beta (VSV-INFB-NIS) Monotherapy and in Combination with Avelumab, in Patients with Refractory Solid Tumors Description: This trial is testing a virus to determine safety, tolerability and preliminary anti-tumor activity for patients who have an advanced cancer that has come back or has not responded to standard therapies, and it is felt that there are no other existing options.
Location:
Sioux Falls Region
Principal Investigator:
Steven Powell, MD
Disease:
Solid Tumors
Stage:
Phase I
Status:
Active - Open to Accrual